Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease

Clinical Infectious Diseases

Volumn 26, Issue 6, 1998, Pages 1448-1458

  Cockerill III, F R ^a   Thompson, R L ^b   Musser, J M ^b   Schlievert, P M ^b   Talbot, J ^b   Holley, K E ^b   Harmsen, W S ^b   Ilstrup, D M ^b   Kohner, P C ^b   Kim, M H ^b   Frankfort, B ^b   Manahan, J M ^b   Steckelberg, J M ^b   Roberson, F ^b   Wilson, W R ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; PENICILLIN G;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; INFANT; INFECTION RISK; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; STRAIN DIFFERENCE; STREPTOCOCCUS INFECTION;

EID: 17344363830     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516376     Document Type: Article

References (30)

1. Stevens DL, Tanner MN, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321:1-7.
2. Auerbach SB, Schwartz B, Williams D, et al. Outbreak of invasive group A streptococcal infections in a nursing home. Arch Intern Med 1992; 152:1017-22.
3. Brogan TV, Nizet V, Waldhausen JHT, Rubens CE, Clarke WR. Group A streptococcal necrotising fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14:588-95.
4. Vugia DJ, Peterson CL, Meyers HB, et al. Invasive group A streptococcal infections in children with varicella in Southern California. Pediatr Infect Dis J 1996; 15:146-50.
5. Musser JM, Kapur V, Peters JE, et al. Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in U.S. Air Force trainees. Arch Pathol Lab Med 1994; 118:128-33.
6. Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. JAMA 1993;269:390-1.
7. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14:2-13.
8. Maslow JN, Stutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular microbiology: principles and applications. 1st ed. Washington, DC: American Society for Microbiology, 1993:563-72.
9. Murray BEK, Singh KV, Heath JD, Sharma BR, et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endo-nucleases with infrequent recognition sites. J Clin Microbiol 1990;28: 2059-63.
10. Miranda AG, Singh KV, Murray BE. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiological tool. J Clin Microbiol 1991;29:2752-7.
11. Harbaugh MP, Podbielski A, Hugl S, Cleary PP. Nucleotide substitutions and small scale insertion produce size and antigenic variation in group A streptococcal Ml protein. Mol Microbiol 1993;8:981-91.
12. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype Ml protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995;63:994-1003.
13. Nelson K, Schlievert PM, Selander RK, Musser JM. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J Exp Med 1991:174:1271-4.
14. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic-shock-like syndrome. J Clin Microbiol 1991;29:1562-7.
15. Schlievert PM, Blomster DA. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983; 147:236-42.
16. Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser JM, Rich RR. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa). Infect Immun 1994; 62:1867-74.
17. Maxted WR, Widdowson JP, Fraser CAM, Ball LC, Bassett DJC. The use of the serum opacity reaction in the typing of group A streptococci. J Med Microbiol 1973;6:83-90.
18. Rotta J, Krause RM, Lancefield RC, Everly W, Lackland H. New approaches for the laboratory recognition of M types of group A streptococci. J Exp Med 1971; 134:1298-315.
19. Griffith F. The serological classification of Streptococcus pyogenes. J Hygiene 1934; 543-84.
20. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-9.
21. Cockerill FR III, MacDonald KL, Thompson RL, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 1997; 277:38-43.
22. Musser JM, Gray BM, Schlievert PM, Pichichero ME. Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. J Clin Microbiol 1992;30:600-3.
23. Davies HE, McGeer A, Schwarte B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335:547-54.
24. Hoge CW, Schwartz B, Talkington D, Brieman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of toxic shock-like syndrome. JAMA 1993;269:384-9.
25. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993;92:710-9.
26. Musser JM, Kapur V, Kanjilal S, et al. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993; 167:337-46.
27. Talkington DF, Schwanz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 193;61:3369-74.
28. Musser JM, Hauser AR, Kim MH, et al. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991;88: 2668-72.
29. Lee PK, Schlievert PM. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness. J Clin Microbiol 1989;27:1890-2.
30. Stevens DL. Streptococcal toxin shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infect Dis 1995; 1:69-78.